Physician profile
Robin Pastore
NPI 1114953791
$3,918.49
in general payments reported to CMS, 2019-2025
27 companies · $1,608 in 2025
The $1,608 reported for 2025 was more than what 79% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $788 · 2020: $178 · 2021: $184 · 2022: $218 · 2023: $495 · 2024: $446 · 2025: $1,608.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,370 · Food and Beverage: $1,148 · Education: $31.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,370.23 |
| Food and Beverage | $1,147.78 |
| Education | $31.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,533.50 | 2025 | |
| Organogenesis INC. | $657.72 | 2020-2024 | Puraply, Affinity |
| Medwest Associates | $464.80 | 2019 | |
| Horizon Therapeutics Plc | $228.34 | 2019-2023 | Krystexxa |
| Smith+Nephew, INC. | $167.36 | 2020-2024 | Grafix Pl |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $158.46 | 2019-2023 | Jublia |
| Kuros Biosciences USA, INC | $121.74 | 2024-2025 | Magnetos |
| Stryker Corporation | $112.58 | 2022-2024 | Augment Injectable |
| Sandoz INC. | $61.62 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $37.37 | 2019 | |
| Alfasigma USA, INC. | $32.34 | 2020-2021 | |
| Arthrosurface Incorporated | $31.64 | 2019 | |
| Orthofix Medical, INC. | $29.57 | 2019-2023 | Physio-Stim |
| Tactile Systems Technology INC | $29.15 | 2019-2020 | |
| Medimetriks Pharmaceuticals, INC. | $28.18 | 2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $27.11 | 2024 | Krystexxa |
| Solventum Corporation | $24.35 | 2025 | Activ.A.C. |
| Zyla Life Sciences, INC. | $21.59 | 2019 | |
| Axogen | $19.96 | 2019 | |
| Paratek Pharmaceuticals, INC. | $19.46 | 2023 | Nuzyra |
| Sebela Pharmaceuticals INC. | $19.39 | 2019 | |
| Depuy Synthes Sales INC. | $18.06 | 2025 | Na |
| Next Science LLC | $17.85 | 2022 | |
| Heron Therapeutics, INC. | $17.71 | 2021 | |
| Paragon 28, INC. | $13.75 | 2023 | Phantom Metatarsal Shortening |
| Merck Sharp & Dohme LLC | $12.89 | 2019 | |
| Kerecis Limited | $12.00 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Pastore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.